We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
How investigators and sponsors should manage clinical trials during COVID-19
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
How to manage and use bed rails safely.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How we're agreeing which new work to start on the Sellafield site due to Covid-19.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Immediate action to clamp down on mistaken releases from prisons and restore public confidence in the criminal justice system has been announced by the Deputy Prime Minister today (Tuesday 11 November).
Information on COVID-19 reinfection surveillance programme in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).